4
Changes in Ownership
RESMED INC Filed Acc 0001127602-23-010519
Chief Executive Officer sold 5,675 shares at $206.95 ($1,174,451)
- Chief Executive Officer acquired 5,675 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2023-03-15 | Option exercise | +5,675 | $57.76 | $327,788 | 442,575 | D |
| Farrell Michael J. Chief Executive Officer | 2023-03-15 | Sale | −5,675 | $206.95 | $1,174,451 | 436,900 | D |
| Derivatives | |||||||
| Farrell Michael J. Chief Executive Officer | 2023-03-15 | Option exercise · ResMed Common Stock Options | −5,675 | 48,865 | D | ||
| Open-market sales · 5,675 sh · avg $206.95 · $1,174,451 | |||||||
Loading xslF345X03/form4.xml…